Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic

Etxeberria I, Bolaños E, Teijeira A, et al. Proc Natl Acad Sci U S A. 2021;118(26):e2025930118. doi:10.1073/pnas.2025930118